Reading RMTI? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.

QuarterlyIQ Insights · RMTI

News & Events

Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.

Type

Direction

10 matches

2026-05-08Item 3.01
RMTI — legal / regulatory event — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 8, 2026, Rockwell Medical, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities maintain a mi…
Legal / regulatorynegative
2026-05-07Item 2.02
RMTI — earnings miss
and Exhibit 99.1 incorporated in this Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings missnegative
2026-03-26Item 2.02
RMTI — earnings beat
and Exhibit 99.1 incorporated in this Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings beatpositive
2026-01-20Item 2.02
RMTI — earnings beat
and Exhibit 99.1 incorporated in this Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing. Forward-Looking Statements Certain statements contained in the press release filed herewith may constitute "forward-looking s…
Earnings preannouncementearnings beatpositive
2025-11-18Item 5.02
RMTI — director transition
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 17, 2025, Andrea Heslin Smiley resigned from the Board of Directors (the “Board”) of Rockwell Medical, Inc. (the “Company”) and all Board committees on which she served, effective immediately. Ms. Smiley’s resignation was not the result of any disagreement between Ms. Smiley and the Company on any matter relating to the Company’s operat…
Executive changedirector transitionneutral
2025-11-12Item 2.02
RMTI — earnings in line
and Exhibit 99.1 incorporated in this Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings inlineneutral
2025-09-29Item 5.02
RMTI — COO transition
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 23, 2025, the Rockwell Medical, Inc. (the “Company”) Board of Directors appointed Heather Hunter as the Company’s Senior Vice President and Chief Operating Officer effective immediately. Ms. Hunter, age 46, most recently served as the Company’s Senior Vice President and Chief Corporate Affairs Officer since August 2022 and an independe…
Executive changecoo transitionneutral
2025-08-14Item 2.02
RMTI — earnings beat
and Exhibit 99.1 incorporated in this Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings beatpositive
2025-05-12Item 2.02
RMTI — earnings miss
and Exhibit 99.1 incorporated in this Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings missnegative
2025-03-20Item 2.02
RMTI — earnings miss
and Exhibit 99.1 incorporated in this Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Earnings preannouncementearnings missnegative

Coming next

General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.